Literature DB >> 24930531

Treatment of group I pulmonary arterial hypertension with carvedilol is safe.

Daniel Grinnan1, Harm-Jan Bogaard, John Grizzard, Benjamin Van Tassell, Antonio Abbate, Christine DeWilde, Anna Priday, Norbert F Voelkel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24930531     DOI： 10.1164/rccm.201311-2025LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  33 in total

Review 1.  The right ventricle and pulmonary hypertension.

Authors:  Mariëlle C van de Veerdonk; Harm J Bogaard; Norbert F Voelkel
Journal:  Heart Fail Rev       Date:  2016-05       Impact factor: 4.214

Review 2.  Neurohormonal modulation as therapeutic avenue for right ventricular dysfunction in pulmonary artery hypertension: till the dawn, waiting.

Authors:  Roy Emanuel; Astha Chichra; Nirav Patel; Thierry H Le Jemtel; Abhishek Jaiswal
Journal:  Ann Transl Med       Date:  2018-08

Review 3.  New and Emerging Therapies for Pulmonary Arterial Hypertension.

Authors:  Edda Spiekerkoetter; Steven M Kawut; Vinicio A de Jesus Perez
Journal:  Annu Rev Med       Date:  2018-09-14       Impact factor: 13.739

Review 4.  Treatment of pulmonary arterial hypertension in children.

Authors:  Heiner Latus; Tammo Delhaas; Dietmar Schranz; Christian Apitz
Journal:  Nat Rev Cardiol       Date:  2015-02-03       Impact factor: 32.419

Review 5.  Right ventricular adaptation and failure in pulmonary arterial hypertension.

Authors:  John J Ryan; Jessica Huston; Shelby Kutty; Nathan D Hatton; Lindsay Bowman; Lian Tian; Julia E Herr; Amer M Johri; Stephen L Archer
Journal:  Can J Cardiol       Date:  2015-01-29       Impact factor: 5.223

Review 6.  Neurohormonal activation and pharmacological inhibition in pulmonary arterial hypertension and related right ventricular failure.

Authors:  Pietro Ameri; Edoardo Bertero; Giovanni Meliota; Martino Cheli; Marco Canepa; Claudio Brunelli; Manrico Balbi
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

Review 7.  Emerging therapies for right ventricular dysfunction and failure.

Authors:  Anna Klinke; Torben Schubert; Marion Müller; Ekaterina Legchenko; Jason G E Zelt; Tsukasa Shimauchi; L Christian Napp; Alexander M K Rothman; Sébastien Bonnet; Duncan J Stewart; Georg Hansmann; Volker Rudolph
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

8.  Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial.

Authors:  Samar Farha; Didem Saygin; Margaret M Park; Hoi I Cheong; Kewal Asosingh; Suzy Aa Comhair; Olivia R Stephens; Emir C Roach; Jacqueline Sharp; Kristin B Highland; Frank P DiFilippo; Donald R Neumann; W H Wilson Tang; Serpil C Erzurum
Journal:  JCI Insight       Date:  2017-08-17

Review 9.  Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and right ventricle in pulmonary arterial hypertension.

Authors:  John J Ryan; Stephen L Archer
Journal:  Circulation       Date:  2015-05-12       Impact factor: 29.690

Review 10.  Diagnosing and treating the failing right heart.

Authors:  John J Ryan; Ryan J Tedford
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.